{"id":"W2115499099","doi":"10.1093/jnci/djp079","title":"Dose Escalation Methods in Phase I Cancer Clinical Trials","year":2009,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":861,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Fondation de France","keywords":"Clinical trial; Medicine; Clinical endpoint; Maximum tolerated dose; Phases of clinical research; Drug; Surrogate endpoint; Pharmacology; Oncology; Drug development; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08421661,0.0005588848,0.006891569,0.0004987524,0.000115955,0.00008884594,0.001389047,0.0009324162,0.0003984273],"category_scores_gemma":[0.4245676,0.0003195833,0.003179689,0.001127155,0.0003243099,0.0003035051,0.0001527578,0.002874904,0.000006707759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001581812,"about_ca_system_score_gemma":0.005247324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001886587,"about_ca_topic_score_gemma":0.00004293351,"domain_scores_codex":[0.9671364,0.01850205,0.01159651,0.0004891626,0.001907922,0.0003679503],"domain_scores_gemma":[0.8820696,0.103936,0.01203378,0.0004029882,0.00129482,0.0002628515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002230427,0.0004868117,0.000004446238,0.00133765,0.0006199031,0.00001182987,0.00001604358,0.00005291518,0.000001414249,0.01407104,0.0109199,0.972255],"study_design_scores_gemma":[0.002758693,0.00009799228,0.00002232582,0.01195945,0.002169523,0.00003540701,0.000001137221,0.00005298216,0.000004628381,0.3511168,0.6315262,0.0002548477],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006025798,0.9402664,0.03505295,0.001158301,0.02048183,0.001791453,0.000636208,0.00001892191,0.0005878469],"genre_scores_gemma":[0.000001313785,0.6759012,0.3161355,0.0003871596,0.007267259,0.0000889193,0.000002357831,0.00003924003,0.0001770411],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9720001,"threshold_uncertainty_score":0.9999256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.9534115106481834,"score_gpt":0.8140813552163118,"score_spread":0.1393301554318717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}